← Back to WP3 Peptides & Research Index

CJC-1295 + Ipamorelin 10mg – Growth Hormone Secretagogue Research Blend

Summary: The CJC-1295 + Ipamorelin blend combines a growth hormone–releasing hormone (GHRH) analog with a selective ghrelin receptor agonist. It is used in non-clinical settings to explore pulsatile GH release, endocrine signaling, and metabolic pathways.

Mechanistic Context

• CJC-1295: Long-acting GHRH analog studied for sustained stimulation of pituitary GH release.
• Ipamorelin: Selective GHS-R agonist investigated for targeted GH secretagogue effects.

Example Research Areas

• GH/IGF-1 axis regulation models
• Muscle protein turnover, recovery, and adaptation studies
• Sleep, circadian rhythm, and endocrine interaction research

Request COA, specifications, or compliance details

For Research Use Only. Not for human or veterinary consumption, diagnostic procedures, or therapeutic use. Content is educational and non-promotional.